ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.
He H, Hao J, Dong X, Wang Y, Xue H, Qu S, Choi SYC, Ci X, Wang Y, Wu R, Shi M, Zhao X, Collins C, Lin D, Wang Y.
He H, et al.
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):775-785. doi: 10.1038/s41391-021-00322-7. Epub 2021 Feb 10.
Prostate Cancer Prostatic Dis. 2021.
PMID: 33568749
Free PMC article.